Dr. Phil Frost Featured in Exclusive Interview at RedChip Emerging Growth
Showcase on Jan. 22-23
25 Emerging Growth Companies Presenting During Online Conference
ORLANDO, Fla., Jan. 17, 2014 (GLOBE NEWSWIRE) -- RedChip Companies, Inc.
("RedChip"), an international small-cap research, investor relations, and
media company, today announced that the RedChip Emerging Growth Showcase on
Wednesday and Thursday, January 22-23, 2014 will feature an exclusive
interview with Dr. Phillip Frost, Chairman and CEO of OPKO Health, Inc. (OPK),
a multinational biopharmaceutical and diagnostics company. Dr. Frost's
interview will air at 9:30 a.m. Eastern time on both days of the conference at
During the RedChip Emerging Growth Showcase, 25 small-cap company executives
will provide detailed overviews of their businesses through video
presentations and live Q&A sessions. Thousands of investors are expected to
participate. The online investor conference will air between 9:30 a.m. and 4
p.m. ET on both days at www.RedChip.com.
Presenting companies range across a broad spectrum of industries and sectors,
including oil & gas, technology, mining, healthcare, consumer goods, energy
and more. Investors can pre-submit a question for a presenting company by
visiting www.RedChip.com/virtualconference. Presenting companies include:
-- Methes Energy (Nasdaq:MEIL) (Jan. 22, 10:30 a.m. ET)
-- Energy Fuels, Inc. (NYSE MKT:UUUU) (TSX:EFR) (Jan. 22, 1:00 p.m. ET)
-- Big North Graphite Corp. (OTC:BNCIF) (Jan. 22, 2:30 p.m. ET)
-- Spherix, Inc. (Nasdaq:SPEX) (Jan. 23, 12:00 p.m. ET)
-- StarStream Entertainment (OTCQB:SSET) (Jan. 23, 2:30 p.m. ET)
For a full list of presenting companies, visit
http://www.redchip.com/virtualconference. No registration is required to
participate in the conference. Start times are subject to change.
About Dr. Phillip Frost
Dr. Frost has successfully founded several pharmaceutical companies and
overseen the development and commercialization of a multitude of
pharmaceutical products. This combined with his experience as a physician and
chairman and/or chief executive officer of large pharmaceutical companies has
given him insight into virtually every facet of the pharmaceutical business
and drug development and commercialization process.
Dr. Frost has been the CEO and Chairman of OPKO since March 2007. Dr. Frost
was named the Chairman of the Board of Teva Pharmaceuticals in March 2010 and
had previously been Vice Chairman since January 2006 when Teva acquired IVAX
Corporation. Dr. Frost had served as Chairman and CEO of IVAX since 1987. He
was Chairman of the Department of Dermatology at Mt. Sinai Medical Center of
Greater Miami from 1972 to 1986. Dr. Frost was Chairman of Key Pharmaceuticals
from 1972 until the acquisition of Key Pharmaceuticals by Schering Plough in
1986. Dr. Frost was named Chairman of Ladenburg Thalmann Financial Services
Inc., in July 2006 and has been a director of Ladenburg Thalmann from 2001
until 2002 and again since 2004. Dr. Frost also serves as Chairman of PROLOR,
a development stage biopharmaceutical company. He serves as a member of the
Board of Trustees of the University of Miami and as a Trustee of each of the
Miami Jewish Home for the Aged and the Mount Sinai Medical Center. Dr. Frost
is also a director of Castle Brands, a developer and marketer of premium brand
spirits. Dr. Frost previously served as a director for Continucare
Corporation, Northrop Grumman Corp., and Ideation Acquisition Corp., as
Governor and Co-Vice-Chairman of the American Stock Exchange and as a member
of the Board of Trustees of the Scripps Research Institute until November
About RedChip Companies, Inc.
RedChip Companies, an Inc. 5000 company, is an international small-cap
research, investor relations, and media company headquartered in Orlando,
Florida; with affiliate offices in San Francisco, Pittsburgh, and Seoul.
RedChip delivers concrete, measurable results for its clients through its
extensive global network of small-cap institutional and retail investors.
RedChip has developed the most comprehensive platform of products and services
for small-cap companies, including: RedChip Research™, Traditional Investor
Relations, Digital Investor Relations, Institutional and Retail Conferences,
Virtual Conferences, "The RedChip Money Report: Small Stocks Big Money"™
television show, Shareholder Intelligence, Strategic Marketing, Crisis
Management, Social Media and Blogging Services, and Webcasts. To learn more
about RedChip's products and services, please visit:
"Discovering Tomorrow's Blue Chips Today"™
CONTACT: Jon Cunningham
RedChip Companies, Inc.
Tel: 1-800-RED-CHIP (733-2447), ext. 107
RedChip Companies Inc. Logo
Press spacebar to pause and continue. Press esc to stop.